These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 18238884

  • 21. Antimicrobial resistance of bacterial isolates from respiratory care wards in Taiwan: a horizontal surveillance study.
    Kuo LC, Yu CJ, Kuo ML, Chen WN, Chang CK, Lin HI, Chen CC, Lu MC, Lin CH, Hsieh WF, Chen LW, Chou Y, Huang MS, Lee CH, Chen SC, Thai SL, Chen PC, Chen CH, Tseng CC, Chen YS, Hsiue TR, Hsueh PR.
    Int J Antimicrob Agents; 2008 May; 31(5):420-6. PubMed ID: 18358701
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Report: prevalence and resistance pattern of Pseudomonas aeruginosa against various antibiotics.
    Khan JA, Iqbal Z, Rahman SU, Farzana K, Khan A.
    Pak J Pharm Sci; 2008 Jul; 21(3):311-5. PubMed ID: 18614431
    [Abstract] [Full Text] [Related]

  • 24. Recovery of antimicrobial-resistant Pseudomonas aeruginosa from sputa of cystic fibrosis patients by culture on selective media.
    Perry JD, Laine L, Hughes S, Nicholson A, Galloway A, Gould FK.
    J Antimicrob Chemother; 2008 May; 61(5):1057-61. PubMed ID: 18316821
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Distribution of multidrug-resistant human isolates of MDR-ACSSuT Salmonella Typhimurium and MDR-AmpC Salmonella Newport in the United States, 2003-2005.
    Greene SK, Stuart AM, Medalla FM, Whichard JM, Hoekstra RM, Chiller TM.
    Foodborne Pathog Dis; 2008 Oct; 5(5):669-80. PubMed ID: 18851677
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H, Colakoğlu S, Turunç T, Demiroğlu YZ, Erdoğan F, Akin S, Arslan H.
    Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
    [Abstract] [Full Text] [Related]

  • 29. [Comparison of antimicrobial use density (AUD) of carbapenem antibacterial agents and investigation of the drug susceptibility of Pseudomonas aeruginosa in 3 hospitals in southern Ibaraki Prefecture, Japan].
    Oishi T, Hitomi S, Kamoshita M, Fukue H, Kawahata D, Fukutake K.
    Rinsho Byori; 2008 Jul; 56(7):570-6. PubMed ID: 18709988
    [Abstract] [Full Text] [Related]

  • 30. Investigation of a nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa.
    Yakupogullari Y, Otlu B, Dogukan M, Gursoy C, Korkmaz E, Kizirgil A, Ozden M, Durmaz R.
    Am J Infect Control; 2008 Dec; 36(10):e13-8. PubMed ID: 19084158
    [Abstract] [Full Text] [Related]

  • 31. Antibiotic susceptibility patterns and clones of Pseudomonas aeruginosa in Swedish ICUs.
    Erlandsson M, Gill H, Nordlinder D, Giske CG, Jonas D, Nilsson LE, Walther S, Hanberger H.
    Scand J Infect Dis; 2008 Dec; 40(6-7):487-94. PubMed ID: 18584536
    [Abstract] [Full Text] [Related]

  • 32. [Clinical research on multi-drug resistant and extensive drug-resistant tuberculosis in Japan].
    Toyota E, Kawabe Y, Yotsumoto H, Sakatani M, Tsuyuguchi K, Maekura R, Fujikawa K, Takashima T, Ogawa K, Yoshiyama T, Sugie T.
    Kekkaku; 2008 Dec; 83(12):773-7. PubMed ID: 19172822
    [Abstract] [Full Text] [Related]

  • 33. Multidrug resistance to antimicrobials as a predominant factor influencing patient survival.
    Giamarellos-Bourboulis EJ, Papadimitriou E, Galanakis N, Antonopoulou A, Tsaganos T, Kanellakopoulou K, Giamarellou H.
    Int J Antimicrob Agents; 2006 Jun; 27(6):476-81. PubMed ID: 16707252
    [Abstract] [Full Text] [Related]

  • 34. Antimicrobial susceptibility profile of Pseudomonas aeruginosa isolates in Egypt.
    Gad GF, el-Domany RA, Ashour HM.
    J Urol; 2008 Jul; 180(1):176-81. PubMed ID: 18499192
    [Abstract] [Full Text] [Related]

  • 35. Antimicrobial susceptibility of Pseudomonas aeruginosa isolates obtained from patients in Canadian intensive care units as part of the Canadian National Intensive Care Unit study.
    Walkty A, Decorby M, Nichol K, Mulvey MR, Hoban D, Zhanel G, Canadian Antimicrobial Resistance Alliance.
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):217-21. PubMed ID: 18304774
    [Abstract] [Full Text] [Related]

  • 36. Classification of OprD sequence and correlation with antimicrobial activity of carbapenem agents in Pseudomonas aeruginosa clinical isolates collected in Japan.
    Sanbongi Y, Shimizu A, Suzuki T, Nagaso H, Ida T, Maebashi K, Gotoh N.
    Microbiol Immunol; 2009 Jul; 53(7):361-7. PubMed ID: 19563394
    [Abstract] [Full Text] [Related]

  • 37. Plasmid mediated amikacin resistance in clinical isolates of Pseudomonas aeruginosa.
    Shahid M, Malik A.
    Indian J Med Microbiol; 2004 Jul; 22(3):182-4. PubMed ID: 17642729
    [Abstract] [Full Text] [Related]

  • 38. Antimicrobial resistance and genetic characterization of fluoroquinolone resistance of Pseudomonas aeruginosa isolated from canine infections.
    Rubin J, Walker RD, Blickenstaff K, Bodeis-Jones S, Zhao S.
    Vet Microbiol; 2008 Sep 18; 131(1-2):164-72. PubMed ID: 18395369
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.